Search results
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Homenewshere.com· 3 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development
Forbes· 1 day agoOver the last three years, various versions of SARS-CoV-2 have mutated to bypass the neutralizing...
House GOP wants criminal referrals for Fauci
The Hill· 15 hours agoAlmost immediately after his Monday hearing, GOP members of the Select Subcommittee on the Coronavirus Pandemic raised calls for possible criminal...
Novavax says it will have an updated Covid vaccine - Washington Business Journal
The Business Journals· 2 days agoThe company said late Wednesday it “expects to be ready for the commercial delivery” of...new...
Will there be a new Covid vaccine in the fall?
NBC News via Yahoo News· 3 days agoDr. Peter Marks, the FDA's top vaccine regulator, urged the committee to consider one of the more recent strains, such as KP.2. “We are paying an...
Analysis | Biden wants hospitals to report data on gunshot wounds
Washington Post· 2 days agoToday’s edition: Doctors are urging the federal government to probe whether the coronavirus can...
The Next COVID-19 Vaccine Is Coming. This Lineage of the Virus Is Its Likely Target.
US News & World Report· 3 days agoVaccine experts on Wednesday endorsed a new target for the next round of COVID-19 shots in the ongoing effort to protect against the ever-changing coronavirus. The vaccine ...
5 takeaways from Fauci’s heated House hearing
The Hill via AOL· 5 days agoDuring his first congressional hearing in nearly two years, former chief White House medical adviser Anthony Fauci picked up where he left off: trading...
Study: Long COVID remains serious and persistent; more than 200 symptoms identified
KIRO 7 Seattle-Tacoma· 21 hours agoA new report from a group that advises federal agencies on science and medicine shows that COVID is...
Novavax's stock surges almost 300% in the past month
AOL· 2 days agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA
